0001654954-26-003895.txt : 20260424 0001654954-26-003895.hdr.sgml : 20260424 20260424112003 ACCESSION NUMBER: 0001654954-26-003895 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260424 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GSK plc CENTRAL INDEX KEY: 0001131399 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15170 FILM NUMBER: 26891416 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 79 NEW OXFORD STREET CITY: LONDON PROVINCE COUNTRY: X0 ZIP: WC1A 1DG BUSINESS PHONE: 44 20 8047 5000 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 79 NEW OXFORD STREET CITY: LONDON PROVINCE COUNTRY: X0 ZIP: WC1A 1DG FORMER COMPANY: FORMER CONFORMED NAME: GSK PLC DATE OF NAME CHANGE: 20220516 FORMER COMPANY: FORMER CONFORMED NAME: GLAXOSMITHKLINE PLC DATE OF NAME CHANGE: 20010105 6-K 1 a8882b.htm DIRECTOR/PDMR SHAREHOLDING a8882b
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of April 2026
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
79 New Oxford Street, London, WC1A 1DG
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
 
GSK plc (the 'Company')
Transaction notification
​
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Maya Martinez-Davis
 
b)
Position/status
President, US
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADS')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account.
 
c)
Price(s) and volume(s)
Price(s)
 
Volume(s)
$55.7000
 
8.572
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume Price
 
 
e)
Date of the transaction
 
2026-04-22
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
 
Registered in England & Wales:
No. 3888792
 
Registered Office:
79 New Oxford Street
London
WC1A 1DG
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: April 24, 2026
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc